Beam Therapeutics Inc
BEAM
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.63B
Close$
$-25.93
201.6% downside
Current Fair Value
201.6% downsideOvervalued by 201.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.63 Billion |
|---|---|
| Enterprise Value | $2.49 Billion |
| Dividend Yield | $0.90 (-) |
| Earnings per Share | $-0.81 |
| Beta | 2.18 |
| Outstanding Shares | 103,262,000 |
Return
| Return on Equity | -5.59% |
|---|---|
| Return on Assets | -4.39% |
| Return on Invested Capital | -5.79% |
Valuation & Multiples
| P/E Ratio | -39.88 |
|---|---|
| PEG | 291.41 |
| Price to Sales | 25.52 |
| Price to Book Ratio | 2.32 |
| Enterprise Value to Revenue | 18.81 |
| Enterprise Value to EBIT | -30.57 |
| Enterprise Value to Net Income | -39 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-1.02
Average shareholder expectationRevenue Estimate
$11.11 M
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-1.11
Average shareholder expectationRevenue Estimate
$16.37 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 52.45% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.70%▼ 100.13% |
|---|---|
| Total Invested | $166.52M▼ 93.54% |
| Investors Holding | 58▼ 205.00% |
ESG Score
No data